In a rodent model of T2D, icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and body weight reduction with ...

Prof. Heiko Lickert is the director of the Institute of Diabetes and Regeneration Research at Helmholtz Munich, professor at the Technical University of Munich (TUM), and member of the German Center ...

A team of researchers has made a breakthrough in diabetes treatment, uncovering a way to regenerate human insulin-producing beta cells. Their discovery, published in Science Translational Medicine, ...

The beta cells even began to slowly reproduce. “mAb43 in combination with insulin therapy may have the potential to gradually reduce insulin use while beta cells regenerate, ultimately eliminating the ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This approach could change how type 1 diabetes is treated, moving beyond just ...

Weill Cornell Medicine has received a four-year, $3.4 million grant from the National Institute of Diabetes and Digestive and ...

Millions of people with type 1 or 2 diabetes worldwide rely on insulin injections or medications to keep their blood sugar in check. The disease results from the destruction of the pancreas’s finite ...

Diogenx SAS raised €27.5 million (US$30.4 million) in a series A round to move a novel therapy for type 1 diabetes into clinical development. The Marseille, France-based company is building on the ...